1 Unit of Medical Oncology and Cancer Prevention, Department of Medical Oncology, Centro di Riferimento Oncologico, Aviano, Italy.
2 Department of Obstetrics and Gynecology, IRCCS, San Raffaele Hospital, Ospedale San Raffaele, Milan, Italy.
3 Department of Oncology, University of Turin, Torino, Piemonte, Italy.
4 Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London, UK.
5 Department of Women and Child Health, Division of Gynecologic Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
6 Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori, Meldola, Emilia-Romagna, Italy.
7 Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Campania, Italy.
8 Department of Biomedical, Surgical, and Dental Sciences, Università degli Studi di Milano, Milan, Italy.
9 Division of Pathology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
10 Multicenter Italian Trials in Ovarian Cancer and Gynecologic Malignancies (MITO) Group Secretariat, Napoli, Italy.
11 Department of Medical Oncology, Azienda Ospedaliera per l'Emergenza Cannizzaro, Catania, Italy.
12 Oncologia Medica, Ospedale S Maria Goretti, Latina, Italy.
13 Department of Life Science and Public Health, Policlinico Universitario Agostino Gemelli Dipartimento Scienze della Salute della Donna e del Bambino, Rome, Lazio, Italy.
14 Department of Medicine, University of Udine, Udine, Italy.
15 Clinical Trials Unit, National Cancer Institute IRCCS Pascale Foundation, Napoli, Italy.
16 Department of Clinical Pathology, Azienda Ospedaliera per l'Emergenza Cannizzaro, Catania, Italy.
17 Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Campania, Italy s.pignata@istitutotumori.na.it.